Publikationen
Assessment of long-term donor-site morbidity after harvesting the latissimus dorsi flap for neonatal myelomeningocele repair
The latissimus dorsi flap (LDF) has been employed very successfully over decades to cover large soft-tissue defects. Its donor-site morbidity has been extensively investigated in adults - but not in children - and is considered to be nonrestrictive. The aim of this long-term study was to assess donor-site morbidity with the modified Constant score more than 8 years after coverage of large myelomeningocele (MMC) defects with a reverse latissimus dorsi flap.
Journal: Journal of Plastic, Reconstructive and Aesthetic Surgery - published online May 2, 2014
DateEnglish: 01/08/20141 Clinic of Hand, Reconstructive and Plastic Surgery, Kantonsspital Aarau, Aarau, Switzerland. Electronic address: Rikthedutch@mac.com.
2 Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.
3 Clinic of Hand, Reconstructive and Plastic Surgery, Kantonsspital Aarau, Aarau, Switzerland.
Fetal surgery for myelomeningocele is effective: a critical look at the whys
Formerly, the disastrous cluster of neurologic deficits and associated neurogenic problems in patients with myelomeningocele (MMC) was generally thought to solely result from the primary malformation, i.e., failure of neurulation.
Journal: Springer Pedicatric Surgery International - Published online: 8 June 2014
DateEnglish: 01/07/20141. Department of Pediatric Surgery, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland, martin.meuli@kispi.uzh.ch.
Kinderchirurgie: Fötale Chirurgie bei Spina bifida
Neues Verständnis der Pathogenese als Grundstein für die intrauterine Chirurgie
Journal: Swiss Medical Forum, (14):976-978
DateEnglish: 01/04/2014a Universitäts-Kinderspital Zürich, Chirurgische Klinik, Steinwiesstrasse 75, 8032 Zürich, Schweiz;
b Klinik für Geburtshilfe, UniversitätsSpital Zürich, Frauenklinikstrasse 10, 8091 Zürich, Schweiz;
c Zentrum für Fetale Diagnostik und Therapie, Frauenklinikstrstrasse 10, 8091 Zürich, Schweiz
Premiere use of Integra™ artificial skin to close an extensive fetal skin defect during open in utero repair of myelomeningocele
There are fetuses demonstrating very large myelomeningocele lesion which can not be covered with autochothonous skin.
Journal: Springer Link Pediatric Surgery International 29, 1321-1326 (2013)
DateEnglish: 22/09/20131 The Zurich Center for Fetal Diagnosis and Therapy, Zurich, Switzerland, martin.meuli@kispi.uzh.ch.
Fetal Surgery for Myelomeningocele: A Critical Appraisal
This article narrates the thrilling story of how the pathogenetic understanding of myelomeningocele was fundamentally revised during the last decades and how these new insights, in particular the "two-hit hypothesis," have prepared the terrain for human fetal surgery. Formerly, the devastating cluster of neurologic and neurogenic problems was mainly attributed to the primary malformation, that is, failure of neurulation. At present, there is solid evidence that in early gestation the nonneurulated spinal cord functions well, but suffers from progressive traumatic and degenerative damage in later gestation because it is openly exposed to the amniotic cavity. There is no doubt that the secondary, in utero acquired spinal cord destruction is mainly responsible for the disastrous and irreversible peripheral neurologic deficit present at birth, and there is no doubt either that timely prenatal protective coverage can potentially arrest these deleterious dynamics and preserve neurologic function. Also, tethering of the cord within and constant outflow of cerebrospinal fluid from the lesion are seen as the driving forces behind the Chiari II malformation and consequent ventriculomegaly. Untethering and watertight sealing of the lesion reverses hindbrain herniation and lowers the risk for a relevant hydrocephalus. This article then details how human fetal surgery started in the late 1990s and follows the evolution from the pioneer case studies via the first case series providing encouraging results to the ground breaking Management of Myelomeningocele Study Trial, published in The New England Journal of Medicine in February 2011 by Adzick et al, that has, for the first time, generated unequivocal evidence that patients with prenatal repair do significantly better than those with postnatal care only. Finally, this review looks at several other critical issues, including the hitherto immature endoscopic approach to fetal repair, some future directions of research and clinical practice, and also utters a plea for concentration of these equally rare and complex cases to a few truly qualified centers worldwide. The conclusion derived from all data existing today is that maternal-fetal surgery, although not a cure and not free of risks, represents a novel standard of care for select mothers and their fetuses suffering from one of the most ruinous nonlethal congenital malformations.
Journal: Georg Thieme Verlag KG European Journal of Pediatric Surgery
DateEnglish: 09/04/20131 Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland. martin.meuli@kispi.uzh.ch